Effects of L-arginine pre-treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s diseases in Balb/c mice

Background: Parkinson’s disease (PD) is a common neurodegenerative disease resulting from the degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc). Increasing evidence demonstrated that mice treated intranasally with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP...

Descripción completa

Detalles Bibliográficos
Autores principales: Hami, Javad, Hosseini, Mehran, Shahi, Sekineh, Lotfi, Nassim, Talebi, Abolfazl, Afshar, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754598/
https://www.ncbi.nlm.nih.gov/pubmed/26885338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754598/
https://www.ncbi.nlm.nih.gov/pubmed/26885338

Ejemplares similares